Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. more
Time Frame | CVRX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -12.12% | -2.06% | -0.55% |
1-Month Return | -12.25% | -1.92% | 2.72% |
3-Month Return | 37.63% | -10.4% | 7.66% |
6-Month Return | 8.24% | -4.6% | 10.15% |
1-Year Return | -50.56% | 4.06% | 27.53% |
3-Year Return | 10.03% | 1.94% | 32.31% |
5-Year Return | -57.29% | 36.48% | 89.2% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 6.26M | 6.05M | 13.04M | 22.47M | 39.30M | [{"date":"2019-12-31","value":15.92,"profit":true},{"date":"2020-12-31","value":15.4,"profit":true},{"date":"2021-12-31","value":33.17,"profit":true},{"date":"2022-12-31","value":57.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 1.68M | 1.44M | 3.64M | 5.00M | 6.26M | [{"date":"2019-12-31","value":26.9,"profit":true},{"date":"2020-12-31","value":23.02,"profit":true},{"date":"2021-12-31","value":58.18,"profit":true},{"date":"2022-12-31","value":79.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 4.57M | 4.61M | 9.40M | 17.47M | 33.04M | [{"date":"2019-12-31","value":13.84,"profit":true},{"date":"2020-12-31","value":13.96,"profit":true},{"date":"2021-12-31","value":28.44,"profit":true},{"date":"2022-12-31","value":52.88,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 73.10% | 76.21% | 72.08% | 77.75% | 84.08% | [{"date":"2019-12-31","value":86.94,"profit":true},{"date":"2020-12-31","value":90.64,"profit":true},{"date":"2021-12-31","value":85.73,"profit":true},{"date":"2022-12-31","value":92.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 14.77M | 16.13M | 35.36M | 60.00M | 76.14M | [{"date":"2019-12-31","value":19.4,"profit":true},{"date":"2020-12-31","value":21.18,"profit":true},{"date":"2021-12-31","value":46.44,"profit":true},{"date":"2022-12-31","value":78.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (10.19M) | (11.51M) | (25.97M) | (42.53M) | (43.10M) | [{"date":"2019-12-31","value":-1019400000,"profit":false},{"date":"2020-12-31","value":-1151400000,"profit":false},{"date":"2021-12-31","value":-2596800000,"profit":false},{"date":"2022-12-31","value":-4252700000,"profit":false},{"date":"2023-12-31","value":-4310300000,"profit":false}] |
Total Non-Operating Income/Expense | (6.09M) | (4.98M) | (19.24M) | 1.04M | 666.00K | [{"date":"2019-12-31","value":-583.51,"profit":false},{"date":"2020-12-31","value":-477.47,"profit":false},{"date":"2021-12-31","value":-1844.49,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.85,"profit":true}] |
Pre-Tax Income | (14.56M) | (14.02M) | (42.99M) | (41.32M) | (41.05M) | [{"date":"2019-12-31","value":-1456000000,"profit":false},{"date":"2020-12-31","value":-1402400000,"profit":false},{"date":"2021-12-31","value":-4298700000,"profit":false},{"date":"2022-12-31","value":-4131900000,"profit":false},{"date":"2023-12-31","value":-4105200000,"profit":false}] |
Income Taxes | 73.00K | 85.00K | 91.00K | 109.00K | (147.00K) | [{"date":"2019-12-31","value":66.97,"profit":true},{"date":"2020-12-31","value":77.98,"profit":true},{"date":"2021-12-31","value":83.49,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-134.86,"profit":false}] |
Income After Taxes | (14.63M) | (14.11M) | (43.08M) | (41.43M) | (40.91M) | [{"date":"2019-12-31","value":-1463300000,"profit":false},{"date":"2020-12-31","value":-1410900000,"profit":false},{"date":"2021-12-31","value":-4307800000,"profit":false},{"date":"2022-12-31","value":-4142800000,"profit":false},{"date":"2023-12-31","value":-4090500000,"profit":false}] |
Income From Continuous Operations | (14.63M) | (14.11M) | (43.08M) | (41.43M) | (42.57M) | [{"date":"2019-12-31","value":-1463300000,"profit":false},{"date":"2020-12-31","value":-1410900000,"profit":false},{"date":"2021-12-31","value":-4307800000,"profit":false},{"date":"2022-12-31","value":-4142800000,"profit":false},{"date":"2023-12-31","value":-4257200000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (14.63M) | (14.11M) | (43.08M) | (41.43M) | (41.20M) | [{"date":"2019-12-31","value":-1463300000,"profit":false},{"date":"2020-12-31","value":-1410900000,"profit":false},{"date":"2021-12-31","value":-4307800000,"profit":false},{"date":"2022-12-31","value":-4142800000,"profit":false},{"date":"2023-12-31","value":-4119900000,"profit":false}] |
EPS (Diluted) | (0.21) | (0.60) | (50.00) | (2.02) | (1.98) | [{"date":"2019-12-31","value":-20.57,"profit":false},{"date":"2020-12-31","value":-60.48,"profit":false},{"date":"2021-12-31","value":-5000,"profit":false},{"date":"2022-12-31","value":-202,"profit":false},{"date":"2023-12-31","value":-198,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
CVRX | |
---|---|
Cash Ratio | 9.15 |
Current Ratio | 11.32 |
Quick Ratio | 10.23 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CVRX | |
---|---|
ROA (LTM) | -31.44% |
ROE (LTM) | -79.02% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CVRX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.49 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.51 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CVRX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 6.76 |
P/B | 4.90 |
Price/FCF | NM |
EV/R | 5.71 |
EV/Ebitda | NM |
CVRx Inc (CVRX) share price today is $11.96
Yes, Indians can buy shares of CVRx Inc (CVRX) on Vested. To buy CVRx Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CVRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of CVRx Inc (CVRX) via the Vested app. You can start investing in CVRx Inc (CVRX) with a minimum investment of $1.
You can invest in shares of CVRx Inc (CVRX) via Vested in three simple steps:
The 52-week high price of CVRx Inc (CVRX) is $33.13. The 52-week low price of CVRx Inc (CVRX) is $6.4.
The price-to-earnings (P/E) ratio of CVRx Inc (CVRX) is
The price-to-book (P/B) ratio of CVRx Inc (CVRX) is 4.90
The dividend yield of CVRx Inc (CVRX) is 0.00%
The market capitalization of CVRx Inc (CVRX) is $319.31M
The stock symbol (or ticker) of CVRx Inc is CVRX